세계의 무좀 시장 : 질환 유형별, 치료 유형별, 투여 경로별, 유통 채널별, 지역별
Global Athlete´s Foot Market, By Disease Type, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography
상품코드
:
1705801
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
전 세계 무좀 시장은 2025년에 14억 1,000만 달러로 추정되며, 2032년에는 19억 9,000만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 연평균 5.0%의 성장률을 보일 것으로 예상됩니다.
| 보고서 범위 |
보고서 상세 |
| 기준 연도 |
2024년 |
2025년 시장 규모 |
14억 1,000만 달러 |
| 실적 데이터 |
2020년부터 2024년까지 |
예측 기간 |
2025년부터 2032년까지 |
| 예측 기간 : 2025-2032년 CAGR |
5.00% |
2032년 가치 예측 |
19억 9,000만 달러 |
그림. 무좀 세계 시장 점유율(%), 지역별, 2025년
발백선이라고도 불리는 무좀은 발 피부, 특히 발가락 사이를 침범하는 흔한 곰팡이 감염이지만 발톱과 손에도 퍼질 수 있습니다. 이 곰팡이는 스포츠 선수들에게서 흔히 볼 수 있는 땀에 젖은 신발 속 등 따뜻하고 습한 환경에서 번식하기 때문에 운동선수들에게 많이 나타나기 때문에 족부백선이라는 이름이 붙여졌습니다. 이 증상의 특징은 발가락 사이와 발바닥의 가려움증, 따끔거림, 작열감입니다. 환부의 피부가 붉게 변하고, 갈라지고, 갈라지고, 수포가 생기기도 합니다. 불쾌한 증상이지만 일반적으로 경미하며 시판되는 항진균제로 치료할 수 있습니다. 심한 경우에는 처방전을 통한 강력한 치료가 필요할 수도 있습니다. 무좀은 피부사상균(피부의 오래된 표피에서 증식하는 진균의 일종)에 의해 발생합니다. 이 곰팡이는 오염된 표면과의 직접적인 접촉이나 수건, 신발, 옷 등과의 간접적인 접촉을 통해 쉽게 퍼집니다. 공동 샤워실, 수영장, 탈의실은 전염의 핫스팟이며, 운동선수나 헬스장 이용자는 특히 감염되기 쉽습니다. 무좀을 예방하기 위해서는 발 위생 관리가 중요한 역할을 합니다. 발을 깨끗하고 건조하게 유지하고, 통기성이 좋은 신발을 신고, 양말을 정기적으로 갈아 신고, 곰팡이가 있을 수 있는 공공장소에서는 맨발로 걷지 않는 것이 중요합니다. 또한, 무좀 환자는 다른 신체 부위나 다른 사람에게 감염을 전파하지 않도록 주의해야 합니다. 무좀의 조기 발견 및 조기 치료는 감염증의 관리가 어려워지거나 더 심각한 이차적인 세균 감염으로 이어지는 것을 예방하는 데 매우 중요합니다. 원인, 예방 및 치료법을 이해하면 이 증상에 효과적으로 대처하고 발의 건강을 유지할 수 있습니다.
시장 역학:
세계 무좀 시장은 주로 노인 인구 증가, 비만율 증가, 물놀이 참여 증가로 인한 감염성 질환의 유병률 증가에 의해 주도되고 있습니다. 치료되지 않은 발 곰팡이 감염의 영향에 대한 건강 인식이 높아짐에 따라 자가 진단과 시판 중인 약품이 증가하고 있습니다. 그러나 일반의약품(OTC) 외용 크림이나 분말을 이용한 가정 요법과 같은 대체 치료 옵션은 처방약의 수익 창출 가능성을 저해할 수 있습니다.
본 조사의 주요 특징
- 세계의 무좀 시장을 상세히 분석하여 2024년을 기준 연도로 하여 예측 기간(2025-2032년)의 시장 규모와 연평균 성장률(CAGR)을 조사 분석하여 전해드립니다.
- 또한, 다양한 부문에 걸친 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 인사이트를 제공합니다.
- 세계 무좀 시장의 주요 기업 프로파일을 회사 개요, 제품 포트폴리오, 주요 특징, 주요 성과, 전략 등의 매개 변수를 기반으로 정리하여 수록하고 있습니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 무좀 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 무좀 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 건강과 위생 인식 확산
- 퍼스널케어와 스포츠 헬스케어에 대한 지출 증가
- 치료 선택사항의 기술적 진보
- 주요 하이라이트
- 규제 시나리오
- 최근 동향
- 제품 발매/승인
- PEST 분석
- PORTER의 분석
- 합병, 인수 및 제휴
제4장 세계의 무좀 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측 분석
- 경제에 대한 영향
제5장 세계의 무좀 시장, 약물 종류별, 2020-2032년
제6장 세계의 무좀 시장, 질환별, 2020-2032년
제7장 세계의 무좀 시장, 투여 경로별, 2020-2032년
제8장 세계의 무좀 시장, 유통 채널별, 2020-2032년
제9장 세계의 무좀 시장, 지역별, 2020-2032년
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동
- 아프리카
제10장 경쟁 구도
- 기업 개요
- Perrigo Company Plc.
- Novartis AG
- Valeant Pharmaceuticals International
- GlaxoSmithKline plc
- Bayer AG
- Teva Pharmaceuticals Industries Ltd.
- Mylan NV
- Glenmark Pharmaceutical Ltd
- Taro Pharmaceutical Industries Ltd.
- Camber Pharmaceuticals Inc
- Aurobindo Pharma Ltd
제11장 섹션
ksm
영문 목차
Global Athlete's foot Market is estimated to be valued at USD 1.41 Bn in 2025 and is expected to reach USD 1.99 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 1.41 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
5.00% |
2032 Value Projection: |
USD 1.99 Bn |
Figure. Global Athlete's foot Market Share (%), By Region 2025
Athlete's foot, also known as tinea pedis, is a common fungal infection that affects the skin on the feet, particularly the spaces between the toes, but can also spread to the toenails and hands. It is named athlete's foot because it is frequently seen in athletes, as the fungus thrives in warm, moist environments, such as the inside of sweaty shoes, which are common among sports participants. This condition is characterized by itching, stinging, and burning sensations between the toes or on the soles of the feet. The affected skin may also become red, flaky, cracked, or blistered. Although the condition can be uncomfortable, it is generally mild and can be treated with over-the-counter antifungal medications. In persistent or severe cases, prescription-strength treatments may be necessary. Athlete's foot is caused by dermatophytes, a type of fungus that grows on the dead outer layer of skin. The fungus spreads easily through direct contact with contaminated surfaces or through indirect contact with towels, shoes, or clothing. Communal showers, swimming pools, and locker rooms are hotspots for transmission, making athletes and gym-goers particularly susceptible. Good foot hygiene plays a crucial role in preventing athlete's foot. This includes keeping the feet clean and dry, wearing breathable footwear, changing socks regularly, and avoiding walking barefoot in public places where the fungus may be present. Individuals with athlete's foot should also be careful not to spread the infection to other parts of their body or to other people. Early detection and treatment of athlete's foot are important to prevent the infection from becoming more difficult to manage or leading to more serious secondary bacterial infections. Understanding the causes, prevention, and treatment options enables individuals to effectively deal with this condition and maintain good foot health.
Market Dynamics:
The global athlete's foot market is primarily driven by the rising prevalence of the infection due to a growing geriatric population, increasing obesity rates, and greater participation in aquatic activities. Growing health awareness regarding implications of untreated fungal infections of feet is also supporting self-diagnosis and over-the-counter medication. However, alternative treatment options such as home remedies using over-the-counter (OTC) topical creams and powders may hinder revenue generation potential for prescription drugs.
Key features of the study:
- This report provides in-depth analysis of the global athlete's foot market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global athlete's foot market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Perrigo Company Plc., Novartis AG, Valeant Pharmaceuticals International, GlaxoSmithKline plc, Bayer AG, Teva Pharmaceuticals Industries Ltd., Mylan NV, Glenmark Pharmaceutical Ltd, Taro Pharmaceutical Industries Ltd., Camber Pharmaceuticals Inc, Aurobindo Pharma Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global athlete's foot market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global athlete's foot market
Detailed Segmentation:
- Global Athlete's Foot Market, By Drug Class
- Global Athlete's Foot Market, By Disease Indication
- Interdigital
- Plantar
- Vesicular
- Global Athlete's Foot Market, By Route of Administration
- Global Athlete's Foot Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Athlete's Foot Market, By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Company Profiles
- Perrigo Company Plc.
- Novartis AG
- Valeant Pharmaceuticals International
- GlaxoSmithKline plc
- Bayer AG
- Teva Pharmaceuticals Industries Ltd.
- Mylan NV
- Glenmark Pharmaceutical Ltd
- Taro Pharmaceutical Industries Ltd.
- Camber Pharmaceuticals Inc
- Aurobindo Pharma Ltd
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Athlete's Foot, By Drug Class
- Market Athlete's Foot, By Disease Indication
- Market Athlete's Foot, By Route of Administration
- Market Athlete's Foot, By Distribution Channel
- Market Athlete's Foot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Growing health and hygiene awareness
- Increasing spending on personal care and sports healthcare
- Technological advancements in treatment options
- Key Highlights
- Regulatory Scenario
- Recent Trends
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Mergers, Acquisitions, and Collaborations
4. Global Athlete's Foot Market- Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Athlete's Foot Market, By Drug Class, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Antifungals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Combination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Global Athlete's Foot Market, By Disease Indication, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Interdigital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Plantar
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Vesicular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Global Athlete's Foot Market, By Route of Administration, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Segment Trends
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Global Athlete's Foot Market, By Distribution Channel, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Global Athlete's Foot Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2020 -2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Company Profile
- Drug Class Portfolio
- Key Developments
- Financial Performance
- Strategies
- Drug Class Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Valeant Pharmaceuticals International
- Drug Class Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Drug Class Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Drug Class Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teva Pharmaceuticals Industries Ltd.
- Company Highlights
- Drug Class Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Drug Class Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Glenmark Pharmaceutical Ltd
- Company Highlights
- Drug Class Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Taro Pharmaceutical Industries Ltd.
- Company Highlights
- Drug Class Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Camber Pharmaceuticals Inc
- Company Highlights
- Drug Class Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Company Highlights
- Drug Class Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- References
- Research Methodology
- About us
관련자료
